Show simple item record

dc.contributor.authorMurphy, R A
dc.contributor.authorFrance, H
dc.contributor.authorSunpath, H
dc.contributor.authorGordon, M L
dc.contributor.authorMarconi, V
dc.contributor.authorKuritzkes, D R
dc.contributor.authorMcIntosh, K
dc.date.accessioned2009-06-30T09:28:37Z
dc.date.available2009-06-30T09:28:37Z
dc.date.issued2009-02
dc.identifier.citationDevelopment of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa. 2009, 55 (1):60-2 J. Trop. Pediatr.en
dc.identifier.issn1465-3664
dc.identifier.pmid18786985
dc.identifier.doi10.1093/tropej/fmn074
dc.identifier.urihttp://hdl.handle.net/10144/71895
dc.description.abstractThe treatment of concurrent HIV and tuberculosis (TB) in children <3 years of age has not been well-studied and is complicated by potential drug-drug interactions. The recommended antiretroviral therapy (ART) in coinfected children in South Africa consists of full-strength ritonavir, lamivudine and stavudine. We report on a child initiated on this regimen, during concurrent TB treatment, who promptly developed an adverse reaction, virologic failure and dual-class antiretroviral drug resistance, compromising subsequent salvage ART.
dc.language.isoenen
dc.publisherPublished by Oxford University Pressen
dc.relation.urlhttp://tropej.oxfordjournals.org/cgi/content/abstract/55/1/60en
dc.rightsPublished by Oxford University Press Archived on this site with kind permission from Oxford University Pressen
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshAntitubercular Agentsen
dc.subject.meshDrug Resistance, Viralen
dc.subject.meshDrug Therapy, Combinationen
dc.subject.meshHIV Infectionsen
dc.subject.meshHIV-1en
dc.subject.meshHumansen
dc.subject.meshInfanten
dc.subject.meshInfant, Newbornen
dc.subject.meshMaleen
dc.subject.meshRNA, Viralen
dc.subject.meshSouth Africaen
dc.subject.meshTreatment Outcomeen
dc.subject.meshTuberculosisen
dc.titleDevelopment of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa.en
dc.contributor.departmentMassachusetts General Hospital, and Brigham and Women's Hospital, Boston, MA, USA. richard.murphy@newyork.msf.orgen
dc.identifier.journalJournal of Tropical Pediatricsen
refterms.dateFOA2019-03-04T14:21:07Z
html.description.abstractThe treatment of concurrent HIV and tuberculosis (TB) in children <3 years of age has not been well-studied and is complicated by potential drug-drug interactions. The recommended antiretroviral therapy (ART) in coinfected children in South Africa consists of full-strength ritonavir, lamivudine and stavudine. We report on a child initiated on this regimen, during concurrent TB treatment, who promptly developed an adverse reaction, virologic failure and dual-class antiretroviral drug resistance, compromising subsequent salvage ART.


Files in this item

Thumbnail
Name:
Development of dual-class ...
Size:
125.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record